lymphoma

Aug 26, 2019

Freenome, ADC Therapeutics Sign Biomarker Development Deal

The companies will use Freenome's platform to identify cancer patients who are most likely to respond to treatment with ADC's loncastuximab tesirine.

Aug 06, 2019

Sophia Genetics Teams With ADC Therapeutics on Biomarker Discovery for Lymphoma Treatment

In a Phase II trial, Sophia will look for genomic markers of clinical response to ADC's treatment for relapsed or refractory diffuse large B-cell lymphoma.

Jun 14, 2019

Kura Oncology Garners Promising Data for T-cell Lymphoma Drug in Biomarker-Defined Population

Premium

CEO Troy Wilson unveiled the first data on tipifarnib demonstrating that biomarkers in the CXCL12 pathway identify which peripheral T-cell lymphoma patients respond best.

Menu

lymphoma

Freenome, ADC Therapeutics Sign Biomarker Development Deal

Sophia Genetics Teams With ADC Therapeutics on Biomarker Discovery for Lymphoma Treatment

Kura Oncology Garners Promising Data for T-cell Lymphoma Drug in Biomarker-Defined Population

Breaking News

Metastatic Tumor Profiles Lead to Potential Treatment Targets

Exact Sciences, Mayo Clinic Launch Real-World Impact Study for Cologuard

Biofidelity Awarded £500K Innovate UK Grant to Develop Noninvasive MDx Tools

Gestalt Diagnostics Enters Collaborations on Cancer Pathology Testing

Study Finds Breast, Ovarian Cancer Gene Tests Cost-Effective for Unselected Breast Cancer Patients

Predictive Oncology Prices $3.2M Public Offering

Sponsorships